Voya Investment Management LLC lifted its stake in Cigna Corporation (NYSE:CI) by 3.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 98,915 shares of the health services provider’s stock after purchasing an additional 3,093 shares during the quarter. Voya Investment Management LLC’s holdings in Cigna Corporation were worth $16,557,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CI. Vanguard Group Inc. boosted its holdings in Cigna Corporation by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock valued at $2,867,514,000 after purchasing an additional 424,469 shares during the last quarter. BlackRock Inc. grew its stake in shares of Cigna Corporation by 2,335.5% in the 1st quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock valued at $2,488,489,000 after buying an additional 16,289,943 shares during the period. State Street Corp grew its stake in shares of Cigna Corporation by 1.7% in the 1st quarter. State Street Corp now owns 11,137,018 shares of the health services provider’s stock valued at $1,631,451,000 after buying an additional 190,323 shares during the period. Wellington Management Group LLP grew its stake in shares of Cigna Corporation by 9.3% in the 1st quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock valued at $1,577,075,000 after buying an additional 913,991 shares during the period. Finally, FMR LLC grew its stake in shares of Cigna Corporation by 6.7% in the 2nd quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock valued at $1,156,604,000 after buying an additional 432,978 shares during the period. 87.94% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Voya Investment Management LLC Acquires 3,093 Shares of Cigna Corporation (CI)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/04/voya-investment-management-llc-acquires-3093-shares-of-cigna-corporation-ci.html.

In related news, Chairman Isaiah Harris, Jr. sold 247 shares of the stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total transaction of $45,761.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Mary T. Hoeltzel sold 525 shares of the stock in a transaction that occurred on Wednesday, August 9th. The stock was sold at an average price of $177.59, for a total transaction of $93,234.75. Following the sale, the vice president now directly owns 1,924 shares of the company’s stock, valued at approximately $341,683.16. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 70,653 shares of company stock worth $12,437,684. Company insiders own 1.30% of the company’s stock.

Several brokerages have recently commented on CI. Deutsche Bank AG upped their price target on Cigna Corporation from $175.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday, July 13th. UBS AG reissued a “buy” rating and set a $193.00 price objective (up from $186.00) on shares of Cigna Corporation in a research report on Thursday, June 22nd. Jefferies Group LLC reissued a “buy” rating and set a $183.00 price objective on shares of Cigna Corporation in a research report on Thursday, June 8th. Royal Bank Of Canada restated a “buy” rating and issued a $177.00 price objective on shares of Cigna Corporation in a report on Tuesday, June 13th. Finally, Bank of America Corporation boosted their price objective on shares of Cigna Corporation from $193.00 to $198.00 and gave the company a “buy” rating in a report on Friday, June 23rd. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $187.67.

Shares of Cigna Corporation (NYSE:CI) opened at 191.99 on Wednesday. The firm’s 50-day moving average is $182.90 and its 200-day moving average is $168.13. Cigna Corporation has a 12-month low of $115.03 and a 12-month high of $192.51. The firm has a market capitalization of $48.34 billion, a price-to-earnings ratio of 22.15 and a beta of 0.43.

Cigna Corporation (NYSE:CI) last announced its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.48 by $0.43. The company had revenue of $10.32 billion during the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The firm’s revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.98 earnings per share. Equities research analysts forecast that Cigna Corporation will post $10.03 EPS for the current fiscal year.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.